Foundayo (orforglipron) is an oral GLP-1 receptor agonist taken once daily as a tablet. Unlike injectable medications such as Wegovy or Zepbound, it requires no injections and no refrigeration, making it a convenient alternative for patients who prefer oral therapy. It is FDA-approved for chronic weight management in adults with obesity or overweight with a weight-related health condition.